Fundraising Fox
/Companies
Sign in

Quarry Thera

New Haven, US · Founded 2024 · Delaware LLC · 23 employees on LinkedIn · 5 known investors

Find your way into Quarry Thera

Sign up to see every warm intro you have to Quarry Thera

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Quarry Thera team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds. It applies two proprietary proximity technologies (SIDTAGs and TISSTAGs) to target biology in immunology and oncology.

BiotechDeep Tech

Founders & leadership

Quarry Thera was founded in 2024 by Craig Crews, Mikael Dolsten, M.D., Ph.D., and Craig Crews, Ph.D..

CCCraig Crews
Craig CrewsCo-Founder & Scientific Advisor
MDMikael Dolsten, M.D., Ph.D.
Mikael Dolsten, M.D., Ph.D.Co-founder and Executive Chairman of the Board
CCCraig Crews, Ph.D.
Craig Crews, Ph.D.Co-Founder & Scientific Advisor
DM
Dan McHughManager
TSTim Shannon
Tim ShannonCEO and Board MemberGeneral Partner at Canaan Partners
JMJeanne Magram
Jeanne MagramChief Scientific Officer
KRKanak Raina
Kanak RainaChief Technology Officer
SCSean Cassidy
Sean CassidyChief Financial Officer
TSTim Shannon, M.D.
Tim Shannon, M.D.CEO and Board Member

Board

MDMikael Dolsten
Mikael DolstenExecutive ChairInvestor at Canaan Partners

Investors · 5

F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M

How we know: F-Prime Capital's portfolio page · Not right? Tell us

Canaan PartnersreportedStamford · $500K – $20M

How we know: funding news · castleplacement.com · Not right? Tell us

Lilly Venturesreported

How we know: funding news · global.pharmcube.com · Not right? Tell us

Also in the syndicate · 1

Eli Lilly

Funding

SEC filings, press & company announcements

$37M disclosed across 2 of 4 rounds · 2025–2026

▶$5MraisedFeb 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan McHughDirector
  • Craig CrewsExecutive Officer, Director
  • Mikael DolstenDirector
Offering amount
$5M
Amount sold
$5M
First sale
Feb 2025
Incorporated
Limited Liability Company, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

PreqinPreqin provides a data and intelligence platform for investment teams, M&A professionals, and corporate development teams to source, evaluate, and value private company investments through integrated asset, fund, and performance data.
F-Prime CapitalBeam Therapeutics develops CRISPR base editing technology to create precision genetic medicines for treating human diseases. The company focuses on therapeutic applications using single-letter DNA modifications.

Companies working in the same space as Quarry Thera.

Frequently asked questions

What does Quarry Thera do?
Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds. It applies two proprietary proximity technologies (SIDTAGs and TISSTAGs) to target biology in immunology and oncology.
Who founded Quarry Thera?
Quarry Thera was founded by Craig Crews, Mikael Dolsten, M.D., Ph.D., Craig Crews, Ph.D. in 2024.
Who are Quarry Thera's investors?
Quarry Thera's investors include Yosemite, F-Prime Capital, Canaan Partners, Lilly Ventures.
How much funding has Quarry Thera raised?
Quarry Thera has disclosed $37M raised across 2 of its 4 known rounds.
Where is Quarry Thera headquartered?
Quarry Thera is headquartered in New Haven, US.